Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate.
Ye G, Bu F, Saxena D, Turner-Hubbard H, Herbst M, Spiller B, Wadzinski BE, Du L, Liu B, Zheng J, Li F.
Ye G, et al. Among authors: li f.
PLoS Pathog. 2024 Nov 26;20(11):e1012726. doi: 10.1371/journal.ppat.1012726. Online ahead of print.
PLoS Pathog. 2024.
PMID: 39591462